The first agreement with a top-tier pharma validates BullFrog's technology and business model. The extended runway reduces near-term dilution risk. Traders should monitor progress on converting this feasibility agreement into a broader multi-program partnership and additional enterprise deals.
Price Chart
Executive Summary
BullFrog AI announced a commercial feasibility agreement with a top 5 global pharmaceutical company to identify drug targets in major depressive disorder using its bfLEAP® platform, and reported a strengthened balance sheet with shareholder equity exceeding $2.5 million, securing runway into late 2027.
Key Facts
- Announced first commercial agreement with a top 5 global pharmaceutical company on March 30, 2026
- Agreement focuses on identifying drug targets in major depressive disorder (MDD), a market projected to exceed $11 billion by 2032
- Platform includes milestone payments and an option for exclusive rights to a final target candidate
- Completed financing activities in late March 2026 resulting in shareholder equity exceeding $2.5 million
- Capital runway extended into late 2027 based on current burn rate
Financial Impact
Shareholder equity exceeds $2.5 million with runway into late 2027; MDD market valued over $8 billion in 2025 and projected to exceed $11 billion by 2032
Risk Factors
- Early-stage company with limited commercial history
- Dependence on successful execution of new commercial relationships
- Highly competitive AI drug discovery market
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-016378 |
| Exhibit: ex99-1.htm | 0001493152-26-016378 |
| Document: 0001493152-26-016378-index-headers.html | 0001493152-26-016378 |
| Document: 0001493152-26-016378-index.html | 0001493152-26-016378 |
| Document: 0001493152-26-016378.txt | 0001493152-26-016378 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
May 29, 2026 21w ago | S-1 | $0.1450 $0.1101 | ▲ +24.07% | ▲ +25.30% | — |
May 1, 2026 25w ago | DEFA14A | $0.1450 | awaiting T+60 | — | — |
Apr 22, 2026 26w ago | 8-K | $0.1450 $0.1249 | ▼ −13.86% | ▼ −18.64% | — |
Apr 13, 2026 28w ago | 8-K | $0.1450 $0.1006 | ▼ −30.62% | ▼ −39.14% | — |
Apr 1, 2026 29w ago | 424B5 | $0.1450 $0.1450 | · 0.00% | ▲ +14.16% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers